April 2026
The global mRNA therapeutics CDMO market size is estimated to hit around USD 14.63 billion by 2035 from USD 5.66 billion in 2026, with a CAGR of 11.14%.
September 2026
The mRNA therapeutics market size was valued at USD 22.30 billion in 2026 and is expected to hit around USD 45.40 billion by 2035, growing at a CAGR of 8.1%.
June 2026
The global peptide therapeutics CDMO market is growing as pharma and biotech companies outsource complex peptide drug development and manufacturing.
June 2026
The mRNA vaccines and therapeutics market size reached USD 116.88 billion in 2025 and is projected to surpass around USD 297.84 billion by 2035 with a CAGR of 9.81%.
July 2025
The U.S. mRNA therapeutics market size was estimated at USD 5.48 billion in 2025 and is projected to hit USD 12.70 billion by 2036, with a notable CAGR of 8.77%
July 2026
The global gene editing & mRNA tool kits market is driving advancements in gene therapy, synthetic biology, and molecular diagnostics worldwide
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The global bispecific antibodies CDMO market expands with demand for next-generation therapeutics, advanced expression systems, and regulatory compliance expertise.
September 2026
The global oral solid dose oncology CDMO market is growing with rising demand for outsourced cancer drug manufacturing and advanced solid dosage formulation.
September 2026
The active pharmaceutical ingredients CDMO market reached USD 125.99 billion in 2026, with key active pharmaceutical ingredients CDMO market companies including Lonza, Thermo Fisher Scientific.
September 2026
The global mRNA synthesis and manufacturing market size is estimated to hit around USD 5.64 billion by 2035 increasing from USD 3.38 billion in 2026, with a CAGR of 5.85%.
September 2026
The U.S. pharmaceutical CDMO market size was calculated at USD 46.55 billion in 2026 and is predicted to reach around USD 83.25 billion by 2034, with a CAGR of 7.47%.
September 2026
The microbiome therapeutics market size reached USD 334.16 million in 2026, with leading microbiome therapeutics market companies including Seres Therapeutics, Nestlé Health Science, Finch Therapeutics.
September 2026
The global bacterial therapeutics market is growing as microbiome-based treatments gain traction in healthcare and biotechnology.
September 2026
The global checkpoint inhibitor biologics CDMO market is growing as demand rises for outsourced biologics development and scalable immuno-oncology manufacturing.
September 2026
The homecare diagnostics & therapeutics market size accounted for USD 291.51 billion in 2026 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The pruritus therapeutics market size stood at USD 12.26 billion in 2026, with major pruritus therapeutics market companies including Bristol-Myers Squibb, Novartis AGÂ , Pfizer Inc.,Teva Pharmaceuticals.
September 2026
The infectious disease therapeutics market size is calculated at USD 37.67 billion in 2026 and is expected to hit around USD 53.48 billion by 2035 at a CAGR of 3.97%.
September 2026
The global veterinary CRO and CDMO market size was valued at USD 8.38 billion in 2026 and is predicted to surpass around USD 17.15 billion by 2035 with a CAGR of 8.30%.
September 2026
The global scleroderma therapeutics market size is projected to surpass around USD 4.48 billion by 2035 increasing from USD 2.88 billion in 2026, with a CAGR of 5.04%.
September 2026
The global small interfering RNA (siRNA) therapeutics market size is estimated to hit around USD 528.78 billion by 2035 increasing from USD 214.41 billion in 2026, with a CAGR of 10.55%.
September 2026
The global melanoma therapeutics market size accounted for USD 8.16 billion in 2026 and is expected to hit around USD 19.61 billion by 2035, at a CAGR of 10.25%.
September 2026
The global targeted therapeutics market size was estimated at USD 91.76 billion in 2026 and is projected to hit around USD 163.91 billion by 2035 with a CAGR of 6.69%.
September 2026
The global non-Hodgkin's lymphoma therapeutics market size is estimated to hit around USD 20.94 billion by 2034, increasing from USD 11.80 billion in 2026, with a CAGR of 7.43%.
September 2026
The anti-inflammatory therapeutics market size was estimated at USD 113.58 billion in 2026 and is expected to hit USD 164.44 billion by 2035, with a CAGR of 4.14%.
September 2026
The global narcolepsy therapeutics market size is accounted at USD 4.46 billion in 2026 and is expected to hit around USD 9.31 billion by 2035 with a CAGR of 8.49%.
September 2026
The global live biotherapeutic products and microbiome CDMO market size is estimated to hit around USD 1,838.56 million by 2035 from USD 106.79 million in 2026, at a CAGR of 37.38%.
September 2026
The global women's health therapeutics market size is predicted to hit around USD 66.62 billion by 2034 from USD 48.57 billion in 2026, with a CAGR of 4.03%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com